1.The change of serum norepinephrine in patients with chronic hepatitis B.
Zong-Gen PENG ; Xiao-Peng LIU ; Dong-Hui SU
Chinese Journal of Applied Physiology 2003;19(4):333-392
Adolescent
;
Adult
;
Case-Control Studies
;
Female
;
Hepatitis B, Chronic
;
blood
;
Humans
;
Male
;
Middle Aged
;
Norepinephrine
;
blood
;
Young Adult
2.A continuous-monitoring procedure of alkaline phosphatase activity with p-acetylphenylphosphace as substrate
Ling WANG ; Zhong-Xin LI ; Dian-Jun WEI ; Xiao-Qin DING ; Zong-Hua HU ; Hui JIN ;
Chinese Journal of Laboratory Medicine 2001;0(03):-
Objective To establish a new determination method for the measuring of alkaline phosphatase activity (ALP) with p-acetyl phenyl phosphace (PAP-PNa_2) as substrate.Methods With the help of Vital semiautomatic analyzer,researched a continuous-monitoring procedure and set up experimental parameters.Results When using this assay,the wavelength of PAP's absorption was 325 nm and the Km of ALP was 0.376 mmol/L.The molecular extinction coefficient of PAP at 340 nm was 23 390 L?mol~(-1)? cm~(-1) and the concentration of citrate buffer was 0.438 mol/L.During the process,we found that the optimum pH of enzyme was 10.4,and the concentration of substrate was 5.0 mmol/L.The time of linear reaction was 900 seconds,and the linear range was 0-1 110 U/L.Serum total ALP were 63.1-118.3 U/ L(male) and 52.5-89.0 U/L(female),based on results from 60 heath adults.Conclusions The method is practical in its repetition and convenience,saves time and is not liable to be affected by bilirubin in serum.It is especially suited to the use of automatic analyzers.
3.Sustentaculum tali screw fixation for the treatment of Sanders type II and III calcaneal fractures.
Zhi-qian GU ; Qing-jiang PANG ; Xiao YU ; Liang CHEN ; Zong-hui GUO
China Journal of Orthopaedics and Traumatology 2015;28(1):31-35
OBJECTIVETo explore the clinical outcomes of open reduction and internal fixation with calcaneal locking plates in treating Sanders type II and III calcaneal fractures.
METHODSFrom January 2010 and October 2012, 38 calcaneal fractures with Sanders type II or III were treated with open reduction and internal fixation with calcaneal locking plate. According to the Sanders classification, 15 fractures were classified as type II, 23 fractures as type III. The patients were divided into two groups (group A and B) according to the different fixed methods. Sustentaculum tali was fixed with one screw in group A, including 13 males and 5 females, with a mean age of (38.56±8.03) years old (ranged, 25 to 55). And sustentaculum tali was not fixed in group B, including 16 males and 4 females, with a mean age of (42.35±8.29) years old (ranged, 29 to 53). Clinical effects were evaluated according to the changes of Böhler's angle and the Maryland Foot Score and VAS score.
RESULTSAll patients were followed up from 12 to 20 months with a mean of 14 months. Böhler's angles and subtalar joints obtained satisfactory reconstruction in all patients. One year after operation, the mean Maryland Foot Score was 88.61±7.59 in group A; and was 82.40±9.24 in group B; Maryland Foot Score of group A was higher and foot functional rehabilitation was better than group B. The mean VAS score was 13.39±11.47 in group A; and was 22.50±13.10 in group B; VAS score of group A was lower and foot pain was less than group B.
CONCLUSIONSustentaculum tall screw fixation has advantages of strong fixed strength, high stability, less postoperative pain, rapid functional recovery in treating Sanders type II and III calcaneal fractures.
Adult ; Bone Plates ; Bone Screws ; Calcaneus ; injuries ; surgery ; Female ; Fracture Fixation, Internal ; methods ; Fractures, Bone ; surgery ; Humans ; Male ; Middle Aged ; Recovery of Function
5.Application of temperature sensitive yeast models with definite target in the screening of potential human Pin1 inhibitors.
Jing ZHANG ; Xiao-Min HAN ; Wen-Hui HU ; Zong-Ru GUO ; Xiao-Bo HE ; Shu-Yi SI
Acta Pharmaceutica Sinica 2014;49(6):854-860
This study is to explore new lead compounds by inhibition of Pin1 for anticancer therapy using temperature sensitive mutants. As Pin1 is conserved from yeast to human, we established a high-throughput screening method for Pin1 inhibitors, which employed yeast assay. This method led to the identification of one potent hits, 8-11. In vitro, 8-11 inhibited purified Pin1 enzyme activity with IC50 of (10.40 +/- 1.68) micromol x L(-1), induced G1 phase arrest and apoptosis, showed inhibitory effects on a series of cancer cell proliferation, reduced Cyclin D1 expression, was defined as reciprocally matched for protein-ligand complex in virtual docking analysis and reduced cell migration ability. In vivo, we could observe reduction of tumor volume after treatment with 8-11 in xenograft mice compared with vehicle DMSO treatment. Altogether, these results provide for the first time the involvement of 8-11 in the anticancer activity against Pin1.
Animals
;
Apoptosis
;
drug effects
;
Cell Proliferation
;
drug effects
;
Cyclin D1
;
metabolism
;
Drug Screening Assays, Antitumor
;
methods
;
G1 Phase
;
High-Throughput Screening Assays
;
methods
;
Humans
;
Mice
;
NIMA-Interacting Peptidylprolyl Isomerase
;
Neoplasms
;
pathology
;
Peptidylprolyl Isomerase
;
antagonists & inhibitors
;
Temperature
;
Xenograft Model Antitumor Assays
;
Yeasts
7.Expression of recombinant human ?-defensin 2 in dermal multipotent stem cells and its antiseptic activity
Nan LI ; Taoyuan XIAO ; Yongping SU ; Hui XU ; Junping WANG ; Zhaowen ZONG ; Xinze RAN ; Shiwu DONG ; Zhijun LIU
Journal of Third Military Medical University 1983;0(04):-
Objective To examine the expression of human ?-defensin 2 (hBD_ 2 ) recombinant adenovirus expression vector in rat dermal multipotent stem cells (dMSCs) and to observe the antiseptic activity of recombinant hBD_ 2 . Methods The expression of hBD_ 2 in dMSCs was examined by RT-PR, fluorescent immunochemistry and Western blotting, and the concentration of recombinant hBD_ 2 in supernate was measured by ELISA. The antiseptic activity of recombinant hBD_ 2 was assessed by K-B disc agar diffusion test. Results hBD_ 2 could be effectively expressed in dMSCs, and the concentration of recombinant hBD_ 2 in supernate was about 743.6 ng/ml . Recombinant hBD_ 2 in supernate showed antiseptic activity. Conclusion Recombinant adenovirus expression vector of hBD_ 2 could be effectively expressed in dMSCs, and the recombinant hBD_ 2 in supernate showed obvious antiseptic effects toward some standard bacteria lines.
8.Repair effect of hBD_2-modified dermal multipotent stem cells transplantation on infected wound
Nan LI ; Taoyuan XIAO ; Yongping SU ; Hui XU ; Junping WANG ; Zhaowen ZONG ; Shiwu DONG ; Xinze RAN ; Zhijun LIU
Journal of Third Military Medical University 1988;0(05):-
Objective To observe the repair effect of human ?-defensin 2 (hBD 2)-modified rat dermal multipotent stem cells (dMSCs) transplantation on infected wound. Methods Thirty Wistar rats were excised a piece of whole-layer back skin, 3 mm in diameter, then infected the wound with 1?10 8/ml pseudomonas aeruginosa 1 ml, then the rats were injected on the wounded back respectively with dMSCs modified by hBD 2 (n=10), or pure dMSCs (n=10) or none as control (n=10). The repair effect was evaluated by observing the amount of bacteria under the scar, wound healing time and the percentage of remaining wound area. Results The amount of bacteria under the scar in rats that were transplanted with dMSCs modified by hBD 2 was less than that in rats transplanted with dMSCs or controls (P
9.Optimization of Technique Conditions for Decolorization and Extract of Exopolysaccharide by Cordyceps jiangxiensis
Jian-Hui XIAO ; Dai-Xiong CHEN ; Jin-Wei LIU ; Zu-Lin LIU ; Wei-Hong WAN ; Zong-Qi LIANG ;
Microbiology 1992;0(03):-
The technique conditions of decolonization of fermentation broth were successively optimized using single factor assay and orthogonal layout method in Cordyceps jiangxiensis. The optimal condition of decolorization was investigated to be 3g/100mL active carbon, 5 min absorption time, pH5 of fermented broth and 25℃absorption temperature. Under the optimal condition, the maximum decolorization rate of fermented broth reached 89. 6% , simultaneously 10. 7% consuming rate of exopolysaccahride was minimum. Subsequently, the extract condition of exopolysaccharide of C. jiangxiensis was further optimized by orthogonal layout design. The maximum exopolysaccharide production was 0. 38 g/L under the optimal condition, i. e. firstly fermented filtrate decolorized and deproteined was concentrated to 1/7 of its total volume, secondly concentration broth was mixed with four times its volume of absolute ethanol and stirred vigorously, lastly precipitation of exopolysaccharide proceeded at 4℃for 16 hrs and the exopolysaccharide collected by centrifugal ion and dryness.
10.Inhibition of virus infection in coxsackievirus-induced myocarditis model by RNA interference.
Hai-Lan YAO ; Feng HE ; Zong-Hui XIAO ; Zhe-Wei LIU
Chinese Journal of Virology 2012;28(5):527-530
To evaluate the effects of lentivirus-delivered short hairpin RNA (shRNA) on CVB3 infection in an animal model by RNA interference technique, we constructed a recombinant lentivirus expressing shRNA-3753 against the viral genome region 3753-3771, then transduced Lenti-sh3753 into mice infected with CVB3. We evaluated the antiviral ability of lenti-sh3753 by cytopathic effect (CPE), viral plaque assay and histological analysis of mice hearts. The results showed that Lenti-sh3753 exhibited a significant protective effect on cell viability and reduction of viral titers in supernatant of cell culture by specific inhibition on viral replication. Lenti-sh3753 also prolonged the mice survival and limited the viral production in mice hearts. These data proposed that Lenti-sh3753 can effectively inhibit CVB3 infection in a coxsackievirus-induced myocarditis model, suggesting its potential role in prevention and therapy of viral diseases.
Animals
;
Coxsackievirus Infections
;
drug therapy
;
virology
;
Down-Regulation
;
Enterovirus B, Human
;
genetics
;
physiology
;
Humans
;
Male
;
Mice
;
Mice, Inbred BALB C
;
Myocarditis
;
drug therapy
;
virology
;
RNA Interference
;
RNA, Small Interfering
;
genetics
;
therapeutic use
;
RNA, Viral
;
genetics
;
Virus Replication